Publicly-traded company Pyxus International Inc. (NYSE:PYX) had a closing price of $10.90 yesterday. Meanwhile, the average 12-month price target from Wall Street analysts is currently $61.00, this means that the stock is underpriced by 82.13%. In the past 52 weeks the company’s stock price has moved within the range of $11.13 to $32.69.
This particular stock’s 5-day moving average is 11.89, its 20-day moving average is 12.53 and its 100-day moving average is 14.11. Pyxus International Inc. (PYX) currently has 9.58M shares outstanding, which means that its market capitalization is $104.42M.
The Details: Pyxus International Inc. (PYX) Financial Health
There are several indicators we can take into consideration when thinking about a stock’s financial health. For example, we can look at a company’s profit margin, which tells us how much of the company’s total sales revenue was kept in earnings. We calculate this figure by dividing net income by net sales revenue. PYX currently has a profit margin of -7.40%.
Looking at a company’s operating margin is also helpful. This number tells us how much profit is kept after considering depreciation and operating expenses. Pyxus International Inc. (PYX) has an operating margin of 4.30%.
Return on Assets, which is expressed as a percentage, tells us how well a public company is using its assets to turn a profit. The larger the percentage, the better it is At the moment, Pyxus International Inc. Return on Assets is -6.70%.
What Does Wall Street Say about Company?
When selecting potential stocks to buy, many investors want to find out what Wall Street professionals are thinking about the company beforehand – like what the average analyst rating is. At the moment, the average analyst rating for PYX is Buy. Out of 1 total analysts who were surveyed, 0 rated it a sell, 0 rated it a underweight, 0 rated it an overweight, 0 rated it hold, and 1 rated it a Buy.
Three months ago, on the other hand, the average analyst rating for Pyxus International Inc. (PYX) was a Buy – from a survey of 2 analysts. Of the analysts who provided ratings, 0 rated the company a Hold, 0 rated it a Sell, 0 rated it an overweight, 0 rated it an underweight, and 2 rated it a Buy.